BMS 140 857 (Sprycel 140 mg)
Generic Name: dasatinib
Pill with imprint BMS 140 857 is White, Round and has been identified as Sprycel 140 mg. It is supplied by Bristol-Myers Squibb.
Sprycel is used in the treatment of chronic myelogenous leukemia; acute lymphoblastic leukemia; leukemia and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Sprycel 140 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for BMS 140 857
Sprycel
- Generic Name:
- dasatinib
- Imprint:
- BMS 140 857
- Strength:
- 140 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- BCR-ABL tyrosine kinase inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Bristol-Myers Squibb
- Inactive Ingredients:
- croscarmellose sodium
hydroxypropyl cellulose
hypromelloses
polyethylene glycol
lactose monohydrate
microcrystalline cellulose
magnesium stearate
titanium dioxide
Note: Inactive ingredients may vary.
More about Sprycel (dasatinib)
- Sprycel Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 15 Reviews
- Drug class: BCR-ABL tyrosine kinase inhibitors
- FDA Alerts (1)
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
